Introduction
- Antipsychotic medications are used for numerous acute states in the emergency department,
- IV access is often not available for patients with agitation and alternative routes must be
- This handout will focus on the pharmacotherapy of the most utilized antipsychotics in the
especially agitation.
considered; the drug of choice may change depending on the route of administration.
emergency department for acute agitation.
Clinical Detail
| Pharmacology | Haloperidol (Haldol®) | Droperidol (Inapsine®) | Olanzapine (Zyprexa®) | Ziprasidone (Geodon®) |
|---|---|---|---|---|
| Dose | PO: 0.5-5 mg IM/IV: 2-5 mg | IM: 5-10 mg IV: 2.5-5 mg | PO: 5-10 mg IM: 5-10 mg | PO: 20-40 mg IM: 10-20 mg |
| Onset | PO: 30-60 min IM: 20-40 min | IV/IM: 5-15 min | PO (ODT): 15-20 min IM: 5-10 min | PO: 45-60 min IM: 15-60 min |
| Elimination Half-life | 10-37 hours | 2-4 hours | 30-37 hours | 2-5 hours |
| Parenteral Concentrations available | 5 mg/1 mL | 2.5 mg/1 mL | Powder for Solution: mix with 2.1 mL sterile water to make 5 mg/1 mL solution | Powder for Solution: Mix with 1.2 mL sterile water for injection 20 mg/1 mL |
| QTc Prolongation (Dose used in study) | 4.7-14.7 mSec (10-15 mg) | +16 mSec women +22 mSec men (4.5 mg) | +6.4 mSec (20 mg) | +15.9 mSec (30 mg) |
| Comments | Give lower dosage range in elderly | Risk of QTc prolongation | BBW for QTc prolongation Frequently on drug shortage | Warning to separate from benzodiazepines administration by 1 hour Caution for QTc prolongation |
Evidence
| Author, year | Design / sample size | Intervention & Comparison | Outcome |
|---|---|---|---|
| Klein, 2018 | Observational n=737 | IM haloperidol 5 mg IM ziprasidone 20 mg IM olanzapine 10 mg IM midazolam 5 mg IM haloperidol 10 mg | At 15 minutes, midazolam resulted in more patients adequately sedated compared with ziprasidone 20 mg, haloperidol 5 mg, haloperidol 10 mg, and olanzapine. At 15 minutes, olanzapine resulted in more patients adequately sedated compared with haloperidol 5 and 10 mg. |
| Taylor, 2017 | RCT n=349 | IV midazolam 5 mg + droperidol 5 mg IV olanzapine 10 mg IV droperidol 10 mg | Ten minutes after the first dose, significantly more patients in the midazolam-droperidol group were adequately sedated compared with the droperidol and olanzapine groups. Patients in the midazolam-droperidol group required fewer additional doses or alternative drugs to achieve adequate sedation. |
| Hsu, 2010 | RCT n=42 | IM haloperidol 7.5 mg IM olanzapine 10 mg ODT olanzapine 10 mg PO risperidone 3 mg | IM olanzapine or orally disintegrating olanzapine tablets showed significantly greater improvement in PANSS-EC scores than did patients who received IM haloperidol at points 15, 30, 45, 60, 75, and 90 minutes after injection. There was no significant difference in effectiveness among intramuscular olanzapine, ODT olanzapine, and oral risperidone solution. |
| Martel, 2005 | RCT n=144 | IM droperidol 5 mg IM ziprasidone 20 mg IM midazolam 5 mg | There were more patients who remained agitated in the ziprasidone group at 15 minutes than in the droperidol and midazolam group. At 45 minutes, there were more agitated patients in the midazolam group than in the droperidol and ziprasidone groups. No cardiac dysrhythmias were identified. |
| Nobay, 2004 | RCT n=111 | IM midazolam 5 mg IM lorazepam 2 mg IM haloperidol 5 mg | The mean time to sedation was 18.3 minutes for midazolam, 28.3 minutes for haloperidol, and 32.2 minutes for lorazepam. (P< 0.05) Time to arousal was 81.9 minutes for patients receiving midazolam, 126.5 minutes for haloperidol, and 217.2 minutes for lorazepam. (P<0.05) |
| Wright, 2001 | RCT n=311 | IM haloperidol 5 mg IM olanzapine 10 mg IM Placebo | Significant differences between olanzapine and haloperidol were observed at 15, 30, and 45 minutes after the first injection in scores on Agitated Behavior Scale, and Agitation Calmness Evaluation Scale. Significant differences between haloperidol and placebo were observed from 30 minutes onward on agitation scores. At 24 hours, changes in QTc intervals with active treatments were not significantly different from those with placebo. |
| Thomas, 1992 | RCT n=21 | IM/IV haloperidol 5 mg IM/IV droperidol 5 mg | Droperidol decreased combativeness significantly more than IM haloperidol at 10 and 30 minutes. There was no significant difference between the two drugs when given by the IV route. |
Conclusions
- Several antipsychotics are commonly used for acute agitation in the emergency department, including haloperidol, droperidol, olanzapine, and ziprasidone, with the drug of choice influenced by the available route of administration.
- These agents differ in onset, elimination half-life, and available parenteral concentrations; in the comparative trials reviewed, olanzapine and droperidol generally achieved adequate sedation faster than haloperidol.
- QTc prolongation is a shared concern across these antipsychotics (olanzapine carries a boxed warning, droperidol and ziprasidone carry QTc cautions), so dosing and monitoring should account for cardiac risk and patient-specific factors such as age.
References
Micromedex [Electronic version].Greenwood Village, CO: Truven Health Analytics. Accessed 2020, September 15.
http://www.micromedexsolutions.com/
Zun LS. J Emerg Med. 2018;54(3):364-374.
Mattson A, et al. Am J Health Syst Pharm. 2020
Miceli JJ, et al. Clin Ther. 2010;32(3):472-491
Yimcharoen P, et al. Gastrointest Endosc. 2006;63(7):979-985.
Haddad PM, Anderson IM. Drugs. 2002;62(11):1649-1671
Klein LR, et al. Ann Emerg Med. 2018;72(4):374-385.
Martel M, et al. Acad Emerg Med. 2006 Feb;13(2):233.
Wright P, et al. Am J Psychiatry. 2001;158(7):1149-1151.
Taylor DM, et al. Ann Emerg Med. 2017;69(3):318-326.e1
Hsu W, et al. J Clin Psychopharmacol. 2010;30(3):230-234.
Thomas H, et al. Ann Emerg Med. 1992;21(4):407-413.
Nobay Fet al,. Acad Emerg Med. 2004;11(7):744-749.
A short weekly clinical Pearl for acute care pharmacists.
Get the Friday Pearl email
Get a short weekly clinical Pearl for acute care pharmacists. No spam.
Free forever. Unsubscribe anytime. No spam.